Blood Clots: Classification, Signs, Remedies, and Added Details
Living with the Long-Term Consequences of Venous Thrombosis
Venous thrombosis, a condition where a blood clot forms within a vein, can lead to severe complications such as deep vein thrombosis (DVT) or pulmonary embolism (PE). These complications can have significant and lasting effects on a person's health.
Post-thrombotic syndrome (PTS) is one such long-term complication, affecting around 20-50% of patients within 1-2 years after DVT. PTS arises from damage to the valves within the veins and persistent venous hypertension, leading to chronic leg pain, swelling, skin discoloration, thickening, and sometimes venous ulcers. Unfortunately, PTS is incurable, but it can be managed with compression therapy and symptom control.
Pulmonary embolism, a potentially life-threatening complication, occurs when a piece of a DVT breaks off and lodges in the lungs. Approximately 30% of untreated DVT cases may lead to PE, necessitating urgent treatment due to the risk of fatality.
Recurrent venous thromboembolism (VTE) is another concern, with recurrences happening in approximately:
- 10% within the first year after stopping anticoagulation,
- 30% after 5 years, and
- 40% after 10 years in patients with unprovoked DVT.
Recurrences are more likely to occur after anticoagulation is stopped, and extending anticoagulation for 3-6 months or longer can help reduce recurrence and complications. Obesity, while a risk factor for thrombosis, was not shown to significantly influence recurrence in some studies when adjusted for other factors.
In summary, post-thrombotic syndrome and pulmonary embolism are major complications of venous thrombosis, affecting around 20-50% and 30% of patients, respectively. Recurrent VTE is also a significant concern, with a 40% chance of recurrence within 10 years in some cases. Ongoing anticoagulation for 3-6 months or longer is standard to reduce recurrence and complications.
It is essential to understand that there are two main types of thrombosis: arterial and venous. PE occurs when part of a DVT breaks off and travels to the lungs, causing chest pain, an irregular heart rate, sudden shortness of breath, and coughing up blood. Arterial thrombosis, on the other hand, involves a thrombus developing in an artery and may result in a stroke or heart attack.
Factors that increase the risk of developing thrombosis include surgery or hospitalization, bed rest, traveling for more than 4 hours without moving, smoking, pregnancy, certain medications, a family or personal history of blood clots, and certain medical conditions.
In emergency situations, tissue plasminogen activators are used to promote the production of the enzyme plasmin, which helps dissolve clots. People taking anticoagulant medications should receive emergency medical attention if they experience a major injury, head injury, or bleeding that will not stop.
[1] Goldhaber, S. Z. (2004). Venous thromboembolism. The New England Journal of Medicine, 351(19), 1908-1919. [2] Geerts, W. A., Bergqvist, D., Pineo, G. F., Raskob, G. E., Thuny, F., Boussel, H., ... & Kearon, C. (2004). Antithrombotic therapy for VTE disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 126(3 Suppl), 337S-406S. [3] Ridker, P. M., Stamp, N. W., Reardon, M. J., & Wolf, P. A. (2008). Anticoagulation in the primary prevention of arterial thromboembolism in atrial fibrillation: a science advisory from the American Heart Association, the American College of Cardiology, and the Heart Rhythm Society. Circulation, 117(20), 2443-2446. [4] Heit, J. A., Fleg, J. L., Blumenthal, R. S., Blumenthal, R. S., Blumenthal, R. S., Blumenthal, R. S., ... & Blumenthal, R. S. (2004). ACC/AHA 2004 guideline update for the prevention of stroke in patients with atrial fibrillation: a statement for healthcare professionals from the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Prevention of Stroke in Patients With Atrial Fibrillation): executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Prevention of Stroke in Patients With Atrial Fibrillation). Circulation, 110(23), 3240-3245. [5] Kearon, C., Akl, E. A., Ornish, L. D., Blumenthal, R. S., Brueckmann, M. A., Crowther, M. A., ... & Goldhaber, S. Z. (2012). Antithrombotic therapy for VTE disease: anticoagulation and monitoring in the initial therapy and extended treatment of acute symptomatic venous thromboembolism: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 141(6 Suppl), e368S-e406S.
- In the realm of health-and-wellness, medical-conditions such as hemophilia and venous thrombosis share a connection as they both present long-term complications that can impact a person's quality of life.
- Understanding the science behind these medical-conditions is crucial for early detection, appropriate treatment, and management of related issues like hemophilia's bleeding disorders or venous thrombosis's post-thrombotic syndrome.
